These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 2332771)
21. Pentostatin (Nipent) in T-cell malignancies. Leukemia Cooperative Group and the European Organization for Research and Treatment of Cancer. Ho AD; Suciu S; Stryckmans P; De Cataldo F; Willemze R; Thaler J; Peetermans M; Döhner H; Solbu G; Dardenne M; Zittoun R Semin Oncol; 2000 Apr; 27(2 Suppl 5):52-7. PubMed ID: 10877053 [TBL] [Abstract][Full Text] [Related]
22. Sezary syndrome in a patient with hairy cell leukemia in remission. Crump M; Sutton DM; Pantalony D Cancer; 1991 Aug; 68(4):829-33. PubMed ID: 1649686 [TBL] [Abstract][Full Text] [Related]
23. Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias. Cheson BD; Vena DA; Barrett J; Freidlin B J Clin Oncol; 1999 Aug; 17(8):2454-60. PubMed ID: 10561309 [TBL] [Abstract][Full Text] [Related]
24. The role of pentostatin in the treatment of T-cell malignancies: analysis of response rate in 145 patients according to disease subtype. Mercieca J; Matutes E; Dearden C; MacLennan K; Catovsky D J Clin Oncol; 1994 Dec; 12(12):2588-93. PubMed ID: 7989933 [TBL] [Abstract][Full Text] [Related]
25. Phase II trials of pentostatin (Nipent) in hairy cell leukemia. Kraut EH Semin Oncol; 2000 Apr; 27(2 Suppl 5):27-31. PubMed ID: 10877048 [TBL] [Abstract][Full Text] [Related]
27. Deoxycoformycin in the treatment of patients with hairy cell leukemia: results of a Spanish collaborative study of 80 patients. Rafel M; Cervantes F; Beltrán JM; Zuazu F; Hernández Nieto L; Rayón C; García Talavera J; Montserrat E Cancer; 2000 Jan; 88(2):352-7. PubMed ID: 10640967 [TBL] [Abstract][Full Text] [Related]
28. [The function of the immune system after the treatment of pediatric malignant diseases]. Gadó J; Schlick B; Bárány O; Németh J; Müller J; Csóka M; Constantin T; Vonnák E; Böcskei R; Hauser P; Kovács G Orv Hetil; 2006 Sep; 147(36):1731-8. PubMed ID: 17087017 [TBL] [Abstract][Full Text] [Related]
29. Induction of apoptosis in vivo and in vitro in hairy cell leukemia treated by deoxycoformycin. Ogawa K; Shichishima T; Nakamura N; Maruyama Y Tohoku J Exp Med; 2000 Sep; 192(1):87-98. PubMed ID: 11128872 [TBL] [Abstract][Full Text] [Related]
30. Long-term outcome following treatment of hairy cell leukemia with pentostatin (Nipent): a National Cancer Institute of Canada study. Johnston JB; Eisenhauer E; Wainman N; Corbett WE; Zaentz SD; Daeninck PJ Semin Oncol; 2000 Apr; 27(2 Suppl 5):32-6. PubMed ID: 10877049 [TBL] [Abstract][Full Text] [Related]
31. Treatment of hairy-cell leukemia: current views. Tallman MS; Peterson LC; Hakimian D; Gillis S; Polliack A Semin Hematol; 1999 Apr; 36(2):155-63. PubMed ID: 10319384 [TBL] [Abstract][Full Text] [Related]
32. 2'-Deoxycoformycin after failure of alpha-interferon in hairy cell leukemia. Durrleman S; Grem JL; Cheson BD Eur J Haematol; 1989 Oct; 43(4):297-302. PubMed ID: 2583256 [TBL] [Abstract][Full Text] [Related]
33. Partial review of immunotherapeutic pharmacology in stem cell transplantation. Bierman PJ; Abe F; Buyukberber S; Ino K; Talmadge JE In Vivo; 2000; 14(1):221-36. PubMed ID: 10757081 [TBL] [Abstract][Full Text] [Related]